| Scorecard |
|---|
|
5 / 5 Stars
|
|
Lipper
5
4
3
5
5
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
B
(Buy)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 0.08 | 0.08 |
| Stocks | 90.39 | 90.39 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 9.53 | 9.53 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 04.30.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 04.30.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Biogen Idec Inc | BIIB | 55.35 | 5.24 |
| International Business Machines Corp | IBM | 10.02 | 4.84 |
| Amgen Inc | AMGN | 16.09 | 2.49 |
| Lockheed Martin Corporation | LMT | 16.74 | 2.37 |
| Thermo Fisher Scientific Inc | TMO | 39.01 | 1.93 |
| Sap AG ADR | SAP | -5.87 | 1.91 |
| F5 Networks, Inc. | FFIV | -18.52 | 1.83 |
| Valeant Pharmaceuticals International Inc | VRX | 47.58 | 1.82 |
| Amphenol Corp | APH | 21.8 | 1.81 |
| Schlumberger NV | SLB | 6.6 | 1.78 |
